| Financial Year |
March 31 2023 |
| Monetary Funds |
432,485,613.76 |
| Held-for-trading Financial Assets |
180,000,000.00 |
| Notes Receivable |
5,607,396.46 |
| Accounts Receivable |
755,066,723.38 |
| Advances to Suppliers |
14,952,500.68 |
| Other Receivables |
4,996,133.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,388,979.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,654,964.33 |
| Total Current Assets |
1,679,748,677.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
718,247.56 |
| Long-term Equity Investment |
3,240,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
225,026,710.13 |
| Under-construction Projects |
151,188,421.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,947,049.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,141,399.22 |
| Deferred Income Tax Assets |
27,126,928.51 |
| Other Non-Current Assets |
70,502,137.12 |
| Sub-Total of Non-Current Assets |
545,329,279.59 |
| Total Assets |
2,225,077,956.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,746,705.56 |
| Accounts Payable |
258,966,640.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,073,595.05 |
| Taxes Payable |
215,607.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,709,083.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,546,304.10 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
392,119,882.61 |
| Long-term Loans |
-- |
| Bonds Payable |
446,985,998.54 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
454,219,950.28 |
| Total Liabilities |
846,339,832.89 |
| Paid-In Capital(Or Share Stock) |
146,940,652.00 |
| Capital Surplus |
554,101,718.16 |
| Surplus Reserve |
63,709,895.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
489,752,454.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,378,738,123.80 |
| Owner's Equity（Stockholder's Equity） |
1,378,738,123.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,225,077,956.69 |
